On Tuesday, Oct. 5, Beaumont is kicking off the Physician Engagement survey. Change the game with your candid responses and help shape the future of Beaumont.
In the coming weeks, you will learn more about how past physician feedback has created lasting change within the organization. Your responses matter. Watch for a link coming to your email on Oct. 5 from email@example.com.
This week, I have a few notes to share:
- Two critical security enhancement required by Tuesday, Sept. 21
- Answering your questions about the COVID-19 vaccine mandate
- Help educate Beaumont employees and the community on the vaccine
- Beaumont study helps lead COVID-19 fight around the world
- Dr. Bhavinkumar D. Dalal earns national recognition
- IT updates
Action required: Two critical security enhancements required by Sept. 21. If you are not enrolled in Duo by Sept. 21, you will be unable to access Beaumont online systems when not on the Beaumont network. Duo is Beaumont’s two-factor authentication solution used for protecting health information against phishing attacks. Please add this to your mobile device before the deadline for uninterrupted service. Also effective on Sept. 21, the Microsoft Outlook application will be the only mobile program used to access Beaumont email. To prepare for these changes, review this information.
As I’m sure you know, Beaumont Health is requiring all team members, regardless of location, to receive the complete dosing regimen of a COVID-19 vaccine by Monday, Oct. 18. Fully employed BMG physicians, all independent physicians who have privileges allowing them to treat patients in the hospital and all physicians who practice at a Beaumont ambulatory site will be required to be vaccinated if they wish to use a Beaumont facility. We know you have questions and appreciate the feedback you have provided. See the FAQs to answer the most common questions. If you have additional questions, please contact your CMO or the Employee Resource Center at 947-522-3466.
I read a very interesting story in the latest Beaumont Research Institute newsletter about how a Beaumont study is helping fight COVID-19 around the world. The Infectious Diseases Society of America recently included results from Beaumont’s BLAST COVID-19 study in its online journal, Clinical Infectious Diseases. The study’s lead author, Dr. Matthew Sims, director of Infectious Disease Research, said the study ultimately helps keep frontline workers safe from COVID-19. Congratulations to Dr. Sims and his team for showcasing Beaumont’s world-class research capabilities on a national scale. Read the full newsletter here.
Seeking physician volunteers to participate in informational sessions about common questions/misperceptions of vaccine safety. These may be done virtually, in-person or through other formats at Beaumont or in the community. To get involved with the education outreach, please email firstname.lastname@example.org by Friday, Sept. 10.
Recently, Dr. Bhavinkumar D. Dalal was awarded the American College of Chest Physicians Distinguished Chest Educator Award, which recognizes the achievements of members of the ACCP who have made significant and long-term contributions to the design and delivery of CHEST education. The DCE award provides national recognition of excellence in continuing medical education.
Until next week,